0
Catabasis Pharmaceuticals, Inc. Banner Image

Catabasis Pharmaceuticals, Inc.

  • Ticker CATB
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Catabasis Pharmaceuticals, Inc. Logo Image
  • 11-50 Employees
  • Based in Boston, Massachusetts
At Catabasis Pharmaceuticals, their mission is to bring hope and life-changing therapies to patients and their families. Their lead program is edasalonexent, an NF-kB inhibitor in Phase 3 development for the treatment of Duchenne muscular dystrophy.
Catabasis Pharmaceuticals, Inc.

Most Recent Annual Report

Catabasis Pharmaceuticals, Inc.
MOST RECENT 2020 Annual Report and Form 10K

Older/Archived Annual Reports